In 2019, Soewarti, a 69-year-old female, was diagnosed with adenocarcinoma of the lung, complicated by a massive pleural effusion on the left side, resulting in significant dyspnea. A biopsy confirmed the malignancy. The patient commenced treatment with oral chemotherapy in conjunction with ECCT as Lung Cancer Treatment recommended by her oncologist.
2019年，69岁的苏瓦尔蒂被诊断出患有肺腺癌，伴有左侧大量胸腔积液，导致显著的呼吸困难。活检证实了恶性肿瘤。患者开始接受口服化疗并配合医生建议的ECCT治疗。Within three months, there was a marked reduction in the pleural effusion, leading to significant relief of her respiratory symptoms. Follow-up imaging indicated that the primary lesion, initially measuring 2-3 cm, had become nearly undetectable. The patient's respiratory function and overall symptomatology improved substantially.
三个月内，胸腔积液明显减少，呼吸症状显著缓解。随访影像显示，最初2-3厘米的病灶几乎无法检测到。患者的呼吸功能和整体症状显著改善。
During the COVID-19 pandemic, the patient experienced a recurrence of dyspnea. Subsequent imaging revealed a regrowth of the mass at the initial tumor site, which had remained stable for three years, along with multiple new lesions in the left lung.
在COVID-19疫情期间，患者再次出现呼吸困难。随后的影像显示，在原始肿瘤部位出现了复发的肿块，该部位已稳定了三年，并在左肺发现了多个新病灶。
Soewarti resumed ECCT with upgraded devices. Remarkably, within three months, there was a reduction in the size of the lesions, with one lesion disappearing entirely.
苏瓦尔蒂重新开始使用升级版的ECCT治疗。值得注意的是，三个月内病灶的大小有所缩小，其中一个病灶完全消失。
After five years, the patient remains in good health with no reported complaints. The most recent CT scan, conducted one year prior, demonstrated further shrinkage of the pulmonary lesions. Soewarti continues to be monitored, showing no signs of disease progression and maintaining a normal quality of life.
五年后，患者身体健康，无任何投诉。最近一次CT扫描（于一年前进行）显示肺部病灶进一步缩小。苏瓦尔蒂继续接受监测，没有显示疾病进展迹象，并保持正常的生活质量。
留言